Abstract:Hepatocellular carcinoma (HCC) is a fatal and dominant form of liver cancer that currently has no effective treatment or positive prognosis. In this study, we explored the antitumor effects of cryptotanshinone (CPT) against HCC and the molecular mechanisms underlying these effects using a systems pharmacology and experimental validation approach. First, we identified a total of 296 CPT targets, 239 of which were also HCC-related targets. We elucidated the mechanisms by which CPT affects HCC through multiple network analysis, including CPT-target network analysis, protein-protein interaction network analysis, target-function network analysis, and pathway enrichment analysis. In addition, we found that CPT induced apoptosis in Huh7 and MHCC97-H ells due to increased levels of cleaved PARP, Bax, and cleaved caspase-3 and decreased Bcl-2 expression. CPT also induced autophagy in HCC cells by increasing LC3-II conversion and the expression of Beclin1 and ATG5, while decreasing the expression of p62/SQSTM1. Autophagy inhibitors (3-methyladenine and chloroquine) enhanced CPT-induced proliferation and apoptosis, suggesting that CPT-induced autophagy may protect HCC cells against cell death. Furthermore, CPT was found to inhibit the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway. Interestingly, activation of PI3K by insulin-like growth factor-I inhibited CPT-induced apoptosis and autophagy, suggesting that the PI3K/AKT/mTOR signaling pathway is involved in both CPT-induced apoptosis and autophagy. Finally, CPT was found to inhibit the growth of Huh7 xenograft tumors. In conclusion, we first demonstrated the antitumor effects of CPT in Huh7 and MHCC97-H cells, both <i>in vitro</i> and <i>in vivo</i>. We elucidated the potential antitumor mechanism of CPT, which involved inducing apoptosis and autophagy by inhibiting the PI3K/Akt/mTOR signaling pathway. Our findings may provide valuable insights into the clinical application of CPT, serving as a potential candidate therapeutic agent for HCC treatment.

Inhibitory Effect of Cryptotanshinone on Angiogenesis and Wnt/β-catenin Signaling Pathway in Human Umbilical Vein Endothelial Cells.

Cryptotanshinone, a Novel Tumor Angiogenesis Inhibitor, Destabilizes Tumor Necrosis Factor‐α Mrna Via Decreasing Nuclear–cytoplasmic Translocation of RNA‐binding Protein HuR

Cryptotanshinone Induces Apoptosis and Inhibits Migration and Invasion in Human Hepatocellular Carcinoma Cells in Vitro

Cryptotanshinone Inhibits TNF-α-induced LOX-1 Expression by Suppressing Reactive Oxygen Species (ROS) Formation in Endothelial Cells

Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular Carcinoma

[Cryptotanshinone Down-Regulates the Expression of VEGF and Inhibits Angiogenesis in U2OS Osteosarcoma Cells].

Suppression of retinal neovascularization by intravitreal injection of cryptotanshinone

Data from Cryptotanshinone Inhibits Cancer Cell Proliferation by Suppressing Mammalian Target of Rapamycin–Mediated Cyclin D1 Expression and Rb Phosphorylation

Antiangiogenic potential of 10-hydroxycamptothecin

Cryptotanshinone Inhibits Cellular Proliferation of Human Lung Cancer Cells Through Downregulation Ofigf-1R/pi3k/akt Signaling Pathway.

Effects of Cryptotanshinone on the Expression Levels of Inflammatory Factors in Myocardial Cells Caused by Ang II and Its Mechanism.

Cryptotanshinone, a Stat3 Inhibitor, Suppresses Colorectal Cancer Proliferation and Growth in Vitro

Cryptanshinone Inhibits the Glycolysis and Inhibits Cell Migration Through PKM2/β-Catenin Axis in Breast Cancer

Effect of Cryptotanshinone on Measures of Rat Cardiomyocyte Oxidative Stress and Gene Activation Associated with Apoptosis

Cryptotanshinone Activates P38/jnk and Inhibits Erk1/2 Leading to Caspase-Independent Cell Death in Tumor Cells

Effect of Tanshinone ⅡA on Endothelial Cell Injured by Serum of Patients with Hypertension

Effect of CPU-XT-008, a Combretastatin A-4 Analogue, on the Proliferation, Apoptosis and Expression of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor in Human Umbilical Vein Endothelial Cells.

Effect of cryptotanshinone on the expression of cell cycle regulatory factors in human breast cancer MCF-7 cells

Cryptotanshinone induces apoptosis of activated hepatic stellate cells via modulating endoplasmic reticulum stress

γ-Tocotrienol inhibits angiogenesis of human umbilical vein endothelial cell induced by cancer cell

Cryptotanshinone Inhibits the Growth of HCT116 Colorectal Cancer Cells Through Endoplasmic Reticulum Stress-Mediated Autophagy